InvestorsHub Logo
icon url

Gsdubb

03/17/14 8:41 PM

#6146 RE: AA_610 #6145

At least 2-3 billion with one product Myocell approved. Then it's up from there. I base that off Mesoblast one of the competitors. They are at about 2 billion with almost the same OS. They are in Australia and don't have an approved product yet. They are approximately 5 years behind Bioheart for the CHF treatment. IMO